ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA approves sNDA for candidiasis treatment in paediatric patients
January 13, 2020Supplemental new drug application (sNDA) has been approved for an expanded indication of MYCAMINE® for the treatment of invasive candidiasis in paediatric patients under four months old. -
FDA approves Astellas’ Mycamine supplemental new drug application
January 13, 2020The US Food and Drug Administration (FDA) has approved Astellas Pharma’s supplemental New Drug Application (sNDA) for Mycamine (micafungin for injection).
Pharma Sources Insight January 2025
